Beihai Gofar Chuanshan Biological Valuation

Is 600538 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 600538 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 600538's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 600538's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 600538?

Key metric: As 600538 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 600538. This is calculated by dividing 600538's market cap by their current revenue.
What is 600538's PS Ratio?
PS Ratio	8x
Sales	CN¥349.37m
Market Cap	CN¥2.71b

600538 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	7.5x
Enterprise Value/EBITDA	-218.8x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 600538's PS Ratio compare to its peers?

The above table shows the PS ratio for 600538 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.1x
603585 Suli	1.3x	n/a	CN¥2.9b
002734 Limin GroupLtd	0.8x	8.3%	CN¥3.4b
600731 Hunan Haili Chemical IndustryLtd	1.5x	n/a	CN¥3.5b
002391 Jiangsu Changqing Agrochemical	1x	14.7%	CN¥3.3b
600538 Beihai Gofar Chuanshan Biological	8x	n/a	CN¥2.7b

Price-To-Sales vs Peers: 600538 is expensive based on its Price-To-Sales Ratio (8x) compared to the peer average (1.1x).

Price to Sales Ratio vs Industry

How does 600538's PS Ratio compare vs other companies in the CN Chemicals Industry?

24 Companies	Price / Sales	Estimated Growth	Market Cap
600346 Hengli PetrochemicalLtd	0.4x	4.3%	US$13.82b
002493 Rongsheng Petrochemical	0.3x	8.5%	US$12.72b
000301 Jiangsu Eastern ShenghongLtd	0.4x	6.8%	US$8.48b
601233 Tongkun Group	0.3x	4.6%	US$3.77b

24 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: 600538 is expensive based on its Price-To-Sales Ratio (8x) compared to the CN Chemicals industry average (2.4x).

Price to Sales Ratio vs Fair Ratio

What is 600538's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

600538 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	8x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 600538's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Yunnan Yuntianhua

CN¥40.2b

Engages in the phosphate ore mining, chemical fertilizers, engineering materials, agriculture, and trade and logistics businesses in China.

600096

CN¥22.04

-3.5%

38.6%

Chifeng Jilong Gold MiningLtd

CN¥28.2b

Operates as a gold and non-ferrous metal mining company.

600988

CN¥17.11

-1.4%

22.3%

Wanhua Chemical Group

CN¥233.8b

Provides polyurethane, petrochemical, and performance chemicals and materials worldwide.

600309

CN¥73.91

-3.6%

-8.4%